Current status of treatment of refractory ascites in patients with liver cirrhosis
Author(s): Shao Jing, Zhang Lei, Han Guohong, Fan Daiming
Pages: 721-723
Year: 2016 Issue: 10
Journal: Chinese Journal of Hepatology
Keyword: Liver cirrhosis; Ascites; Therapy;
Abstract: Ascites is a common clinical manifestation of cirrhotic portal hypertension,and about 60％-80％ of cirrhotic patients develop the symptom of ascites within 10 years.Once ascites occurs,the 5-year survival rate is reduced from 80％ to 50％.With the progression of liver diseases,approximately 5％-10％ of patients with ascites develop refractory ascites,and the median survival time is only 6-12 months.This article reviews the definition and diagnosis of refractory ascites,evaluation of prognostic factors,and treatment regimens,including large-volume paracentesis combined with protein supplementation,transjugular intrahepatic portosystemic shunt,and liver transplantation.
Pages: 721-723
Year: 2016 Issue: 10
Journal: Chinese Journal of Hepatology
Keyword: Liver cirrhosis; Ascites; Therapy;
Abstract: Ascites is a common clinical manifestation of cirrhotic portal hypertension,and about 60％-80％ of cirrhotic patients develop the symptom of ascites within 10 years.Once ascites occurs,the 5-year survival rate is reduced from 80％ to 50％.With the progression of liver diseases,approximately 5％-10％ of patients with ascites develop refractory ascites,and the median survival time is only 6-12 months.This article reviews the definition and diagnosis of refractory ascites,evaluation of prognostic factors,and treatment regimens,including large-volume paracentesis combined with protein supplementation,transjugular intrahepatic portosystemic shunt,and liver transplantation.
Related Articles